Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/IM8N stock hub

FRA/IM8N has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/IM8Nis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/IM8N

In the news

Latest news · FRA/IM8N

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-294.5

P25 n/aP50 n/aP75 n/a

ROIC-42.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/IM8N market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	1,664
Employees Change	393%
Employees Change Percent	30.92
Enterprise value	EUR 18.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 18.7B
Price	EUR 86.98
Price currency	EUR
Rev Per Employee	427,168.18x
Sic	2836
Symbol	fra/IM8N
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.5%
EV Earnings	-17.78x
EV/FCF	-22.84x
EV/Sales	26.22x
FCF yield	-4.28%
P/B ratio	30.53x
P/S ratio	26.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-117.77%
EBITDA Margin	-115.8%
Gross margin	81.81%
Gross Profit	EUR 581.5M
Gross Profit Growth	130.04%
Gross Profit Growth Q	261.37%
Gross Profit Growth3 Y	49.49%
Gross Profit Growth5 Y	36.55%
Net Income	EUR -1B
Pretax Margin	-143.76%
Profit Margin	-144.44%
Profit Per Employee	EUR -616,990
ROA	-31.11
Roa5y	-25.98
ROCE	-56.29
ROE	-294.5
ROIC	-42.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.59%
Cagr15y	20.67%
Cagr1y	37.01%
Cagr3y	76.55%
Cagr5y	26.55%
Revenue Growth	115.09x
Revenue Growth Q	229.62x
Revenue Growth3 Y	47.1x
Revenue Growth5 Y	37.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.42
Assets	EUR 1.8B
Cash	EUR 1.1B
Current Assets	EUR 1.4B
Current Liabilities	EUR 306.1M
Debt	EUR 643.9M
Debt Equity	EUR 1.05
Debt FCF	EUR -0.81
Equity	EUR 611.3M
Interest Coverage	-11.73
Liabilities	EUR 1.2B
Long Term Assets	EUR 432.5M
Long Term Liabilities	EUR 883M
Net Cash	EUR 417.2M
Net Cash By Market Cap	EUR 2.24
Net Debt Equity	EUR -0.68
Tangible Book Value	EUR 429.3M
Tangible Book Value Per Share	EUR 1.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.47
Inventory Turnover	1.28
Net Working Capital	EUR 32.2M
Quick ratio	3.88
Working Capital	EUR 1.1B
Working Capital Turnover	EUR 0.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	800.79%
1Y total return	36.98%
200-day SMA	132.4
3Y total return	450.51%
50-day SMA	123.5
50-day SMA vs 200-day SMA	50under200
5Y total return	224.55%
All Time High	185
All Time High Change	-52.98%
All Time High Date	2025-12-02
All Time Low	2.02
All Time Low Change	4,212.35%
All Time Low Date	2012-05-07
ATR	4.96
Ch YTD	-41.23
High	92.8
High52	185
High52 Date	2025-12-02
High52ch	-52.98%
Low	84.88
Low52	58
Low52 Date	2025-05-23
Low52ch	49.97%
Ma50ch	-29.54%
Price vs 200-day SMA	-34.3%
RSI	21.6
RSI Monthly	48.11
RSI Weekly	33.3
Sharpe ratio	0.68x
Sortino ratio	1.04
Total Return	-20.64%
Tr YTD	-41.23
Tr15y	1,575.92%
Tr1m	-37.42%
Tr1w	-25.65%
Tr3m	-31.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -837.1M
Operating margin	-117.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	193,494,327%
Net Borrowing	-4,255,921.3
Shares Insiders	0.62%
Shares Institutions	92.9%
Shares Qo Q	0.86%
Shares Yo Y	20.64%
Short Ratio	5.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -937.4M
Average Volume	116.6x
Bv Per Share	2.82
CAPEX	EUR -22.5M
Ch10y	800.8
Ch15y	1,575.9
Ch1m	-37.42
Ch1w	-25.65
Ch1y	36.98
Ch3m	-31.51
Ch3y	450.5
Ch5y	224.6
Ch6m	-44.95
Change	-5.03%
Change From Open	-4.32
Close	91.59
Days Gap	-0.74
Depreciation Amortization	13,720,873.1
Dollar Volume	28,181.5
Earnings Date	2026-05-07
EBIT	EUR -837.1M
EBITDA	EUR -823.1M
EPS	EUR -4.95
F Score	4
FCF	EUR -799.3M
FCF EV Yield	-4.38x
Financing CF	827,915,040
Fiscal Year End	December
Founded	1,988
Goodwill	115,416,107.8
Income Tax	EUR 4.8M
Investing CF	104,538,271
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2011-03-03
Last Split Type	Reverse
Ma150	140
Ma150ch	-37.88%
Ma20	118.1
Ma20ch	-26.33%
Net CF	155,195,529
Open	90.91
Position In Range	26.52
Ppne	173,181,823.1
Price Date	2026-05-08
Ptbv Ratio	43.47
Relative Volume	3.07x
Revenue	710,807,857x
SBC By Revenue	19.43x
Share Based Comp	138,075,895
Tax By Revenue	0.68x
Tr6m	-44.95%
Volume	324
Z Score	7.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/IM8N pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/IM8N stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/IM8N?

Insider, institutional, and short-interest positioning.

Institutional ownership

+92.9%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/IM8N momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

21.6

Below 30: short-term oversold

Price vs 200-day MA

-34.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/IM8N

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/IM8N stock rating?

fra/IM8N is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/IM8N analysis?

The full report lives at /stocks/fra/IM8N/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/IM8N?

The latest report frames fra/IM8N around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/IM8N page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.